Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2024 is 21.91% vs 64.04% in Mar 2023
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2024 is 19.62% vs 20.38% in Mar 2023
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2024 is 18.96% vs 41.64% in Mar 2023
Compare Balance Sheet Results of Fredun Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.70
38.21
-33.51
-87.70%
Share Warrants & Outstandings
Total Reserve
115.20
521.45
-406.25
-77.91%
Shareholder's Funds
121.47
559.66
-438.19
-78.30%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
12.80
0.00
12.80
0.00%
Secured Loans
12.80
0.00
12.80
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
4.14
18.80
-14.66
-77.98%
Other Long Term Liabilities
0.00
21.61
-21.61
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.37
2.56
-0.19
-7.42%
Total Non-Current Liabilities
19.30
42.98
-23.68
-55.10%
Current Liabilities
Trade Payables
62.95
32.70
30.25
92.51%
Other Current Liabilities
11.17
22.12
-10.95
-49.50%
Short Term Borrowings
92.71
88.51
4.20
4.75%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
166.83
143.33
23.50
16.40%
Total Liabilities
307.60
745.97
-438.37
-58.77%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
62.98
260.33
-197.35
-75.81%
Less: Accumulated Depreciation
16.40
33.07
-16.67
-50.41%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
46.57
227.25
-180.68
-79.51%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
4.87
-4.87
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
101.85
-101.85
-100.00%
Long Term Loans & Advances
3.36
46.09
-42.73
-92.71%
Other Non Current Assets
0.46
24.70
-24.24
-98.14%
Total Non-Current Assets
50.40
431.61
-381.21
-88.32%
Current Assets Loans & Advances
Current Investments
0.81
0.00
0.81
0.00%
Inventories
175.00
38.10
136.90
359.32%
Sundry Debtors
64.85
134.18
-69.33
-51.67%
Cash and Bank
1.35
64.20
-62.85
-97.90%
Other Current Assets
1.44
29.43
-27.99
-95.11%
Short Term Loans and Advances
13.76
48.45
-34.69
-71.60%
Total Current Assets
257.20
314.36
-57.16
-18.18%
Net Current Assets (Including Current Investments)
90.37
171.03
-80.66
-47.16%
Total Current Assets Excluding Current Investments
256.39
314.36
-57.97
-18.44%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
307.60
745.97
-438.37
-58.77%
Contingent Liabilities
0.00
10.34
-10.34
-100.00%
Total Debt
105.51
88.51
17.00
19.21%
Book Value per share (adjusted)
255.15
14.65
240.50
1,641.64%
Annual - Borrowings
Borrowings 105.51 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 21.91% vs 64.04% in Mar 2023
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 46.57 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 19.62% vs 20.38% in Mar 2023
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 257.20 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 18.96% vs 41.64% in Mar 2023






